Sudden cardiac death in nonischemic cardiomyopathy

Rikin S. Kadakia, Mark Steven Link, Paari Dominic, Daniel P. Morin

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Sudden cardiac death (SCD)is a major cause of mortality in patients with nonischemic cardiomyopathy (NICM). Identifying patients who are at highest risk for SCD is an ongoing challenge. At present, guidelines recommend the use of an implantable cardioverter-defibrillator (ICD)in patients with NICM with a reduced left ventricular ejection fraction (LVEF)and heart failure (HF)symptoms. Some recent data, however, suggest that ICDs may not increase longevity in this population. Conversely, community-based studies have demonstrated that many at-risk individuals who may benefit from ICD therapy remain unprotected. Current recommendations for ICD implantation are continually debated, justifying comprehensive individualized risk assessment. Various promising techniques for further risk stratification are under evaluation, including cardiac magnetic resonance imaging, electrocardiographic assessment of electrical instability, and genetic testing. However, none of these strategies has been fully adapted into guidelines. Hence, clinical risk stratification practice today depends on LVEF and HF symptoms, which have poor sensitivity and specificity for predicting SCD risk.

Original languageEnglish (US)
JournalProgress in Cardiovascular Diseases
DOIs
StatePublished - Jan 1 2019

Fingerprint

Sudden Cardiac Death
Cardiomyopathies
Implantable Defibrillators
Stroke Volume
Heart Failure
Guidelines
Genetic Testing
Magnetic Resonance Imaging
Sensitivity and Specificity
Mortality
Population

Keywords

  • Implantable cardioverter-defibrillator
  • Nonischemic cardiomyopathy
  • Risk stratification
  • Sudden cardiac death

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Sudden cardiac death in nonischemic cardiomyopathy. / Kadakia, Rikin S.; Link, Mark Steven; Dominic, Paari; Morin, Daniel P.

In: Progress in Cardiovascular Diseases, 01.01.2019.

Research output: Contribution to journalReview article

@article{74634f2fd2494b509e311811f6ba8777,
title = "Sudden cardiac death in nonischemic cardiomyopathy",
abstract = "Sudden cardiac death (SCD)is a major cause of mortality in patients with nonischemic cardiomyopathy (NICM). Identifying patients who are at highest risk for SCD is an ongoing challenge. At present, guidelines recommend the use of an implantable cardioverter-defibrillator (ICD)in patients with NICM with a reduced left ventricular ejection fraction (LVEF)and heart failure (HF)symptoms. Some recent data, however, suggest that ICDs may not increase longevity in this population. Conversely, community-based studies have demonstrated that many at-risk individuals who may benefit from ICD therapy remain unprotected. Current recommendations for ICD implantation are continually debated, justifying comprehensive individualized risk assessment. Various promising techniques for further risk stratification are under evaluation, including cardiac magnetic resonance imaging, electrocardiographic assessment of electrical instability, and genetic testing. However, none of these strategies has been fully adapted into guidelines. Hence, clinical risk stratification practice today depends on LVEF and HF symptoms, which have poor sensitivity and specificity for predicting SCD risk.",
keywords = "Implantable cardioverter-defibrillator, Nonischemic cardiomyopathy, Risk stratification, Sudden cardiac death",
author = "Kadakia, {Rikin S.} and Link, {Mark Steven} and Paari Dominic and Morin, {Daniel P.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.pcad.2019.05.002",
language = "English (US)",
journal = "Progress in Cardiovascular Diseases",
issn = "0033-0620",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Sudden cardiac death in nonischemic cardiomyopathy

AU - Kadakia, Rikin S.

AU - Link, Mark Steven

AU - Dominic, Paari

AU - Morin, Daniel P.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Sudden cardiac death (SCD)is a major cause of mortality in patients with nonischemic cardiomyopathy (NICM). Identifying patients who are at highest risk for SCD is an ongoing challenge. At present, guidelines recommend the use of an implantable cardioverter-defibrillator (ICD)in patients with NICM with a reduced left ventricular ejection fraction (LVEF)and heart failure (HF)symptoms. Some recent data, however, suggest that ICDs may not increase longevity in this population. Conversely, community-based studies have demonstrated that many at-risk individuals who may benefit from ICD therapy remain unprotected. Current recommendations for ICD implantation are continually debated, justifying comprehensive individualized risk assessment. Various promising techniques for further risk stratification are under evaluation, including cardiac magnetic resonance imaging, electrocardiographic assessment of electrical instability, and genetic testing. However, none of these strategies has been fully adapted into guidelines. Hence, clinical risk stratification practice today depends on LVEF and HF symptoms, which have poor sensitivity and specificity for predicting SCD risk.

AB - Sudden cardiac death (SCD)is a major cause of mortality in patients with nonischemic cardiomyopathy (NICM). Identifying patients who are at highest risk for SCD is an ongoing challenge. At present, guidelines recommend the use of an implantable cardioverter-defibrillator (ICD)in patients with NICM with a reduced left ventricular ejection fraction (LVEF)and heart failure (HF)symptoms. Some recent data, however, suggest that ICDs may not increase longevity in this population. Conversely, community-based studies have demonstrated that many at-risk individuals who may benefit from ICD therapy remain unprotected. Current recommendations for ICD implantation are continually debated, justifying comprehensive individualized risk assessment. Various promising techniques for further risk stratification are under evaluation, including cardiac magnetic resonance imaging, electrocardiographic assessment of electrical instability, and genetic testing. However, none of these strategies has been fully adapted into guidelines. Hence, clinical risk stratification practice today depends on LVEF and HF symptoms, which have poor sensitivity and specificity for predicting SCD risk.

KW - Implantable cardioverter-defibrillator

KW - Nonischemic cardiomyopathy

KW - Risk stratification

KW - Sudden cardiac death

UR - http://www.scopus.com/inward/record.url?scp=85066294791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066294791&partnerID=8YFLogxK

U2 - 10.1016/j.pcad.2019.05.002

DO - 10.1016/j.pcad.2019.05.002

M3 - Review article

C2 - 31075279

AN - SCOPUS:85066294791

JO - Progress in Cardiovascular Diseases

JF - Progress in Cardiovascular Diseases

SN - 0033-0620

ER -